Title |
Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
|
---|---|
Published in |
Clinical Interventions in Aging, July 2015
|
DOI | 10.2147/cia.s85808 |
Pubmed ID | |
Authors |
Yan Cai, Seong Soo A An, SangYun Kim |
Abstract |
Alzheimer's disease (AD) is the most common form of dementia. Mutations in the genes encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have been identified as the main genetic causes of familial AD. To date, more than 200 mutations have been described worldwide in PSEN1, which is highly homologous with PSEN2, while mutations in PSEN2 have been rarely reported. We performed a systematic review of studies describing the mutations identified in PSEN2. Most PSEN2 mutations were detected in European and in African populations. Only two were found in Korean populations. Interestingly, PSEN2 mutations appeared not only in AD patients but also in patients with other disorders, including frontotemporal dementia, dementia with Lewy bodies, breast cancer, dilated cardiomyopathy, and Parkinson's disease with dementia. Here, we have summarized the PSEN2 mutations and the potential implications of these mutations in dementia-associated disorders. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 298 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 59 | 20% |
Student > Ph. D. Student | 46 | 15% |
Student > Master | 40 | 13% |
Researcher | 17 | 6% |
Student > Doctoral Student | 13 | 4% |
Other | 28 | 9% |
Unknown | 97 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 60 | 20% |
Neuroscience | 30 | 10% |
Medicine and Dentistry | 23 | 8% |
Agricultural and Biological Sciences | 23 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 18 | 6% |
Other | 41 | 14% |
Unknown | 105 | 35% |